OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-ZA76         View EO 12866 Meetings	Received Date: 07/22/2020
Title: Cannabidiol Enforcement Policy; Draft Guidance for Industry; Availability
Agency/Subagency: HHS / FDA
Concluded Action: Withdrawn	Concluded Date: 01/21/2021
Publication Date:
Regulatory Flexibility Analysis Required: No	Small Entities Affected: No
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No